Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or notherapy in preventing hepatitis B (HBV) recurrence after livertransplantation (LT)

✍ Scribed by P. Andreone; G.L. Grazi; A. Gramenzi; C. Cursaro; M. Biselli; P. Caraceni; M.C. Morelli; C. Sama; E. Iovine; M. Del Gaudio; R. Bellusci; A. Mazziotti; A. Cavallari; M. Bernardi

• Book ID: 119525863
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 141 KB
• Volume: 32
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(00)80526-7